1103496

Michael R. Liebowitz, M.D. — FEI 2433132

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)